Motomiya, Y.; Kaneko, Y.; Motomiya, Y.; Higashimoto, Y. Serum Levels of the C-Terminal Fragment of Fibroblast Growth Factor 23 (C-FGF23) and Hepcidin in Patients With Hemodialysis Undergoing Treatment With a Proline Hydroxylase Domain (PHD) Inhibitor. J Clini Nephrol 2024, 8, 132-137.